{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:49:22Z","timestamp":1756460962794},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.rmcr.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T21:46:41Z","timestamp":1543009601000},"page":"59-62","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature"],"prefix":"10.1016","volume":"26","author":[{"given":"Shuko","family":"Hirota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naho","family":"Kagiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Takayanagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2018.11.013_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.rmcr.2018.11.013_bib2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmcr.2018.11.013_bib3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1183\/09031936.00139513","article-title":"Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis","volume":"43","author":"Moss","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmcr.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmcr.2018.11.013_bib5","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmcr.2018.11.013_bib6","doi-asserted-by":"crossref","first-page":"31813","DOI":"10.3402\/ecrj.v3.31813","article-title":"Severe asthma: anti-IgE or anti-IL-5?","volume":"3","author":"Papathanassiou","year":"2016","journal-title":"Eur. Clin. Respir. J."},{"issue":"1","key":"10.1016\/j.rmcr.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/02770903.2017.1306548","article-title":"Omalizumab versus Mepolizumab as add-on therapy in asthma patients not well controlled on at least an inhaled corticosteroid: a network meta-analysis","volume":"55","author":"Nachef","year":"2018","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmcr.2018.11.013_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.rmed.2016.12.009","article-title":"Comparative effectiveness of mepolizumab and omalizumab in severe asthma: an indirect treatment comparison","volume":"123","author":"Cockle","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmcr.2018.11.013_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/thx.2004.035519","article-title":"Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody","volume":"62","author":"van der Ent","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.rmcr.2018.11.013_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2016.11.019","article-title":"Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature","volume":"122","author":"Li","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmcr.2018.11.013_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"6","key":"10.1016\/j.rmcr.2018.11.013_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2500\/aap.2015.36.3909","article-title":"Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: one center's experience with 14 cases","volume":"36","author":"Aydin","year":"2015","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.rmcr.2018.11.013_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jaip.2017.01.013","article-title":"Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis","volume":"5","author":"Altman","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmcr.2018.11.013_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12890-018-0617-5","article-title":"A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"18","author":"Terashima","year":"2018","journal-title":"BMC Pulm. Med."},{"issue":"4","key":"10.1016\/j.rmcr.2018.11.013_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.alit.2018.03.004","article-title":"Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"67","author":"Oda","year":"2018","journal-title":"Allergol. Int."},{"key":"10.1016\/j.rmcr.2018.11.013_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomized trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"Agarwal","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmcr.2018.11.013_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01159-2018","article-title":"A randomized trial of voriconazole and prednisolone monotherapy in acute-stage ABPA complicating asthma","volume":"52","author":"Agarwal","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmcr.2018.11.013_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/02770903.2015.1127935","article-title":"A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis","volume":"53","author":"Ram","year":"2016","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmcr.2018.11.013_bib19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.chest.2018.01.005","article-title":"A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"153","author":"Agarwal","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rmcr.2018.11.013_bib20","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.2500\/ar.2015.6.0128","article-title":"Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis","volume":"6","author":"Beam","year":"2015","journal-title":"Allergy Rhinol. (Providence)"},{"key":"10.1016\/j.rmcr.2018.11.013_bib21","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood-2012-05-432088","article-title":"Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans","volume":"121","author":"Ueki","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rmcr.2018.11.013_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.alit.2017.08.002","article-title":"Mucus plugging in allergic bronchopulmonary aspergillosis: implication of the eosinophil DNA traps","volume":"67","author":"Omokawa","year":"2018","journal-title":"Allergol. Int."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007118303368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007118303368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T12:09:22Z","timestamp":1568117362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007118303368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":22,"alternative-id":["S2213007118303368"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2018.11.013","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}